Munich - Delayed Quote EUR
Celyad Oncology (1C0.MU)
0.5040
-0.0040
(-0.79%)
At close: May 5 at 8:06:45 AM GMT+2
Key Executives
Key Executives Information Not Available
Celyad Oncology
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Celyad Oncology’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 2, 2025 at 5:00 PM UTC
Celyad Oncology Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
CSCI COSCIENS Biopharma Inc.
3.7000
-2.89%
PRTC PureTech Health plc
17.84
+1.65%
DRTS Alpha Tau Medical Ltd.
2.6000
0.00%
DSGN Design Therapeutics, Inc.
4.3600
-6.24%
FBLG FibroBiologics, Inc.
0.9512
-5.82%
PLRZ Polyrizon Ltd.
1.1400
+12.87%
ENTX Entera Bio Ltd.
2.2900
-2.97%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2900
-5.15%
EQ Equillium, Inc.
0.4002
-4.49%
CDTX Cidara Therapeutics, Inc.
21.50
-0.88%